Preview Mode Links will not work in preview mode

Apr 8, 2020

Proceedings from the Second Annual Miami General Medical Oncology Symposium — Part 11: Lung Cancer. Featuring perspectives from Drs Hossein Borghaei, Leora Horn, Stephen V Liu and Gregory J Riely.

  • Immune Checkpoint Inhibitors in Lung Cancer
    • Immune Checkpoint Inhibitors in Locally Advanced and Small Cell Lung Cancer — Dr Liu
    • Factors Affecting the Selection of First-Line Therapy for Metastatic Non-Small Cell Lung Cancer (NSCLC); Role of PD-L1 in Current Decision-Making — Dr Borghaei
  • Targeted Treatment of Lung Cancer
    • First-Line Treatment for Patients with Metastatic EGFR-Mutated NSCLC and CNS Metastases — Dr Riely
    • Treatment of BRAF-, NTRK- and RET-Positive NSCLC — Dr Horn

CME information and select publications